TG20, a Transgenically-Derived Anti-CD20 Monoclonal Antibody, Exhibits Enhanced Cytotoxicity Against Cells with Low Levels of CD20.

Drug Category : Array
Conference Category : Array
Lead Author : Echelard Y, Meade HM, et al.
Published Date : 13/12/2011
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/ASH2011Poster2730.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top